izpis_h1_title_alt

Correlation between the serum concentration of vitamin A and disease severity in patients carrying p.G90D in RHO, the most frequent gene associated with dominant retinitis pigmentosa : implications for therapy with vitamin A
ID Krašovec, Tjaša (Author), ID Kobal, Nina (Author), ID Šuštar Habjan, Maja (Author), ID Volk, Marija (Author), ID Hawlina, Marko (Author), ID Fakin, Ana (Author)

.pdfPDF - Presentation file, Download (3,94 MB)
MD5: FBBF024AF41F929E21A4738D866661FB
URLURL - Source URL, Visit https://www.mdpi.com/1422-0067/24/1/780 This link opens in a new window

Abstract
The pathogenic variant p.G90D in RHO is believed to be responsible for a spectrum of phenotypes, including congenital stationary blindness (for the purpose of this study termed night blindness without degeneration; NBWD), Sector RP, Pericentral RP, and Classic RP. We present a correlation between the serum concentration of vitamin A and disease severity in patients with this variant. This prospective study involved 30 patients from 7 families (17 male; median age 46 years, range 8–73). Full ophthalmological examination including visual acuity, Goldmann perimetry, slit-lamp exam, optical coherence tomography, fundus autofluorescence, and electrophysiology was performed to determine the presenting phenotype. The serum concentration of vitamin A was determined from a fasting blood sample taken on the day of the exam, where it was found that 23.3% (7/30) of patients had NBWD, 13.3% (4/30) had Sector RP, 3.3% (1/30) had Pericentral RP, and 60% (18/30) had Classic RP. Multiple logistic regression revealed a significantly higher probability of having a milder phenotype (NBWD or Sector RP) in association with younger age (p < 0.05) and a higher concentration of vitamin A (p < 0.05). We hypothesize that vitamin A in its 11-cis-retinal form plays a role in stabilizing the constitutively active p.G90D rhodopsin and its supplementation could be a potential treatment strategy for p.G90D RHO patients.

Language:English
Keywords:retinitis pigmentosa, RP, vitamin A, CSNB, NBWD, congenital stationary night blindness, rhodopsin, RHO, sector RP, treatment
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:14 str.
Numbering:Vol. 24, iss. 1, art. 780
PID:20.500.12556/RUL-155549 This link opens in a new window
UDC:617.7
ISSN on article:1422-0067
DOI:10.3390/ijms24010780 This link opens in a new window
COBISS.SI-ID:147522819 This link opens in a new window
Publication date in RUL:05.04.2024
Views:522
Downloads:177
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:pigmentni retinitis, RP, vitamin A, CSNB, NBWD, prirojena stacionarna nočna slepota, rodopsin, RHO, sektor RP, zdravljenje

Projects

Funder:ARRS - Slovenian Research Agency
Project number:J3-1750
Name:Priprava pogojev za gensko zdravljenje dednih očesnih bolezni

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back